Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-10-02
1983-04-12
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 22, 544 25, C07D50140, A61K 31545
Patent
active
043797873
ABSTRACT:
Broad spectrum cephalosporin antibiotics represented by the formula ##STR1## wherein R is an amino-substituted oxazole, oxadiazol, or isoxazole heterocyclic, R' is C.sub.1 -C.sub.4 alkyl, a carboxysubstituted alkyl or cycloalkyl group, etc., and .sup..sym. R.sub.1 is an oximino-substituted pyridinium, quinolinium or isoquinolinium group, e.g., .sup..sym. R.sub.1 is a 3- or 4-formylpyridinium oxime group; pharmaceutical compositions comprising the antibiotic, and a method for treating antibacterial infections are provided.
REFERENCES:
patent: 4200575 (1980-04-01), Numata et al.
patent: 4258041 (1981-03-01), O'Callaghan et al.
patent: 4267176 (1981-05-01), Kamiya et al.
Nomura et al., J. Med. Chem. 1974, vol. 17, No. 12, pp. 1312-1315.
Derwent Abstract 32890.
Lunn William H. W.
Wheeler William J.
Eli Lilly and Company
Gerstl Robert
Scanlon William B.
Whale Arthur R.
LandOfFree
Oximino-substituted cephalosporin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oximino-substituted cephalosporin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oximino-substituted cephalosporin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-938515